Basic Information
RNALocate ID: | RLID:11001946 |
RNA Symbol: | hsa-miR-185-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-185-5p |
RNA ID: | miRBase:MIMAT0000455 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001842 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001843 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001844 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001845 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11001942 | Exosome | Plasma | 29130611 |
RLID:11001943 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001944 | Exosome | Breast milk | 22211110 |
RLID:11001945 | Exosome | Brain tissue | 23382797 |
RLID:11001947 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001948 | Exosome | Serum | 25135963 |
RLID:11001949 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11001950 | Microvesicle | Plasma | 23077538 |
RLID:11001951 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001952 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000100 | Exosome | Blood|Tongue tissue | |
RLID-D:11000383 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-185-5p | Idiopathic pulmonary fibrosis | MNDR-E-MI-20977 |
MNDR | hsa-miR-185-5p | Medulloblastoma | MNDR-E-MI-20978 |
MNDR | hsa-miR-185-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-20979 |
MNDR | hsa-miR-185-5p | Lymphoma | MNDR-E-MI-20980 |
MNDR | hsa-miR-185-5p | Cutaneous t cell lymphoma | MNDR-E-MI-20981 |
MNDR | hsa-miR-185-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-20982 |
MNDR | hsa-miR-185-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-20983 |
MNDR | hsa-miR-185-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-20984 |
MNDR | hsa-miR-185-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-20985 |
MNDR | hsa-miR-185-5p | Her2-receptor positive breast cancer | MNDR-E-MI-20986 |
MNDR | hsa-miR-185-5p | Breast cancer luminal | MNDR-E-MI-20987 |
MNDR | hsa-miR-185-5p | Anencephaly | MNDR-E-MI-20988 |
MNDR | hsa-miR-185-5p | Neurofibromatosis 1 | MNDR-E-MI-20989 |
MNDR | hsa-miR-185-5p | Prostate cancer | MNDR-E-MI-20990 |
MNDR | hsa-miR-185-5p | Prostate carcinoma | MNDR-E-MI-20991 |
MNDR | hsa-miR-185-5p | Gastric cancer | MNDR-E-MI-20992 |
MNDR | hsa-miR-185-5p | Wolfram syndrome | MNDR-E-MI-20993 |
MNDR | hsa-miR-185-5p | Alzheimer disease | MNDR-E-MI-20994 |
MNDR | hsa-miR-185-5p | Intracranial aneurysm | MNDR-E-MI-20995 |
MNDR | hsa-miR-185-5p | Esophageal carcinoma | MNDR-E-MI-20996 |
MNDR | hsa-miR-185-5p | Dysautonomia familial | MNDR-E-MI-20997 |
MNDR | hsa-miR-185-5p | Polycystic ovary syndrome | MNDR-E-MI-20998 |
MNDR | hsa-miR-185-5p | Head and neck cancer | MNDR-E-MI-20999 |
MNDR | hsa-miR-185-5p | Cardiovascular disease | MNDR-E-MI-21000 |
MNDR | hsa-miR-185-5p | Moyamoya disease | MNDR-E-MI-21001 |
MNDR | hsa-miR-185-5p | Lung cancer | MNDR-E-MI-21002 |
MNDR | hsa-miR-185-5p | Parkinson disease | MNDR-E-MI-21003 |
MNDR | hsa-miR-185-5p | Breast cancer | MNDR-E-MI-21004 |
MNDR | hsa-miR-185-5p | Pituitary neoplasms | MNDR-E-MI-21005 |
MNDR | hsa-miR-185-5p | Pancreatic cancer | MNDR-E-MI-21006 |
MNDR | hsa-miR-185-5p | Malignant melanoma | MNDR-E-MI-21007 |
MNDR | hsa-miR-185-5p | Rectum adenocarcinoma | MNDR-E-MI-21008 |
MNDR | hsa-miR-185-5p | Nephroblastoma | MNDR-E-MI-21009 |
MNDR | hsa-miR-185-5p | Colon cancer | MNDR-E-MI-21010 |
MNDR | hsa-miR-185-5p | Colon adenocarcinoma | MNDR-E-MI-21011 |
MNDR | hsa-miR-185-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-21012 |
MNDR | hsa-miR-185-5p | Ovarian cancer | MNDR-E-MI-21013 |
MNDR | hsa-miR-185-5p | Acromegaly | MNDR-E-MI-21014 |
MNDR | hsa-miR-185-5p | Carcinoma ductal breast | MNDR-E-MI-21015 |
MNDR | hsa-miR-185-5p | Glioblastoma | MNDR-E-MI-21016 |
MNDR | hsa-miR-185-5p | Glioma | MNDR-E-MI-21017 |
MNDR | hsa-miR-185-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-21018 |
MNDR | hsa-miR-185-5p | Chordoma | MNDR-E-MI-21019 |
MNDR | hsa-miR-185-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-21020 |
MNDR | hsa-miR-185-5p | Osteosarcoma | MNDR-E-MI-21021 |
MNDR | hsa-miR-185-5p | Liposarcoma | MNDR-E-MI-21022 |
MNDR | hsa-miR-185-5p | Meningioma | MNDR-E-MI-21023 |
MNDR | hsa-miR-185-5p | Liver cancer | MNDR-E-MI-21024 |
MNDR | hsa-miR-185-5p | Uterine cancer | MNDR-E-MI-21025 |
MNDR | hsa-miR-185-5p | Cervical adenocarcinoma | MNDR-E-MI-21026 |
MNDR | hsa-miR-185-5p | Gastric adenocarcinoma | MNDR-E-MI-21027 |
MNDR | hsa-miR-185-5p | Cervical squamous cell carcinoma | MNDR-E-MI-21028 |
MNDR | hsa-miR-185-5p | Pituitary adenoma | MNDR-E-MI-21029 |
MNDR | hsa-miR-185-5p | Lung squamous cell carcinoma | MNDR-E-MI-21030 |
MNDR | hsa-miR-185-5p | Non-small cell lung cancer | MNDR-E-MI-21031 |
MNDR | hsa-miR-185-5p | Lung adenocarcinoma | MNDR-E-MI-21032 |
MNDR | hsa-miR-185-5p | Thyroid carcinoma | MNDR-E-MI-21033 |
MNDR | hsa-miR-185-5p | Bladder urothelial carcinoma | MNDR-E-MI-21034 |
MNDR | hsa-miR-185-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-21035 |
MNDR | hsa-miR-185-5p | Carcinoma renal cell | MNDR-E-MI-21036 |
MNDR | hsa-miR-185-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-21037 |
MNDR | hsa-miR-185-5p | Clear cell renal cell carcinoma | MNDR-E-MI-21038 |
MNDR | hsa-miR-185-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-21039 |
MNDR | hsa-miR-185-5p | Large cell carcinoma | MNDR-E-MI-21040 |
MNDR | hsa-miR-185-5p | Esophageal cancer | MNDR-E-MI-21041 |
MNDR | hsa-miR-185-5p | Liver cirrhosis | MNDR-E-MI-21042 |
MNDR | hsa-miR-185-5p | Oncocytoma | MNDR-E-MI-21043 |
MNDR | hsa-miR-185-5p | Stomach carcinoma | MNDR-E-MI-21044 |
MNDR | hsa-miR-185-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-21045 |
MNDR | hsa-miR-185-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-21046 |
MNDR | hsa-miR-185-5p | Fibromyalgia | MNDR-E-MI-21047 |
MNDR | hsa-miR-185-5p | Encephalomyelitis | MNDR-E-MI-21048 |
MNDR | hsa-miR-185-5p | Breast invasive carcinoma | MNDR-E-MI-21049 |
MNDR | hsa-miR-185-5p | Early hepatocellular carcinoma | MNDR-E-MI-21050 |
MNDR | hsa-miR-185-5p | Malignant pleural mesothelioma | MNDR-E-MI-21051 |
MNDR | hsa-miR-185-5p | Retinoblastoma | MNDR-E-MI-21052 |
MNDR | hsa-miR-185-5p | Neuroblastoma | MNDR-E-MI-21053 |
MNDR | hsa-miR-185-5p | Hodgkin lymphoma | MNDR-E-MI-21054 |
MNDR | hsa-miR-185-5p | Dementia vascular | MNDR-E-MI-21055 |
MNDR | hsa-miR-185-5p | Tonsil cancer | MNDR-E-MI-21056 |
MNDR | hsa-miR-185-5p | Psoriasis | MNDR-E-MI-21057 |
MNDR | hsa-miR-185-5p | Acute myelocytic leukemia | MNDR-E-MI-21058 |
MNDR | hsa-miR-185-5p | Colorectal cancer | MNDR-E-MI-21059 |
MNDR | hsa-miR-185-5p | Multiple myeloma | MNDR-E-MI-21060 |
MNDR | hsa-miR-185-5p | Ependymoma | MNDR-E-MI-21061 |
MNDR | hsa-miR-185-5p | Hearing loss noise-induced | MNDR-E-MI-21062 |
MNDR | hsa-miR-185-5p | Cardiomegaly | MNDR-E-MI-21063 |
MNDR | hsa-miR-185-5p | Sleep deprivation | MNDR-E-MI-21064 |
MNDR | hsa-miR-185-5p | Epstein-barr virus infections | MNDR-E-MI-21065 |
MNDR | hsa-miR-185-5p | Stroke lacunar | MNDR-E-MI-21066 |
MNDR | hsa-miR-185-5p | Breast cancer her3+ negative | MNDR-E-MI-21067 |
MNDR | hsa-miR-185-5p | High grade dysplastic nodule | MNDR-E-MI-21068 |
MNDR | hsa-miR-185-5p | HPV | MNDR-E-MI-21069 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCG4 | Homo sapiens | RR00024860 |
TOP